Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic Amant

Showing results (131-140 of 180) with videos related to

Pageof 18
Sort By:
JMIR Research Protocols|June 24, 2025
The First 6 Years' Experiences of a National Centralized Offspring Surveillance Setting for Dutch Children Prenatally Exposed to Maternal Cancer to Inform Future International Practice: Protocol for a Demographic Review of Referred Families and Key Lessons LearnedEvangeline A Huis In 't Veld, Anouk M Kruse, Emma J Verwaaijen, et al.
Breast Cancer Research and Treatment|October 25, 2006
Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imagingLeilani Morales, Steven Pans, Robert Paridaens, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 24, 2011
ESGO statement on the role of CA-125 measurement in follow-up of epithelial ovarian cancerAte G J van der Zee, Nicoletta Colombo, Gerald Gitsch, et al.
Gynecologic Oncology|June 23, 2019
PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumorsMonica Tang, Rachel L O'Connell, Frederic Amant, et al.
Carcinogenesis|December 15, 2010
Progesterone receptor gene variants and risk of endometrial cancerTracy A O'Mara, Paul Fahey, Kaltin Ferguson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2010
Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosisVanya Van Belle, Ben Van Calster, Olivier Brouckaert, et al.
Breast (Edinburgh, Scotland)|April 29, 2014
Prediction of non-sentinel lymph node involvement in breast cancer patients with a positive sentinel lymph nodeAnneleen Reynders, Olivier Brouckaert, Ann Smeets, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|June 26, 2024
Maternal death by cancer in pregnancy: A descriptive study of the International Network on Cancer, Infertility and PregnancyJoosje H Heimovaara, Evangeline A Huis In 't Veld, Christianne A R Lok, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 2, 2015
Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesionsSabrina Croce, Agnes Ribeiro, Celine Brulard, et al.
Bioinformatics (Oxford, England)|August 23, 2024
MetDecode: methylation-based deconvolution of cell-free DNA for noninvasive multi-cancer typingAntoine Passemiers, Stefania Tuveri, Dhanya Sudhakaran, et al.
Pageof 18

Showing results (131-140 of 180) with videos related to

Sort By:
Pageof 18
JMIR Research Protocols|June 24, 2025
The First 6 Years' Experiences of a National Centralized Offspring Surveillance Setting for Dutch Children Prenatally Exposed to Maternal Cancer to Inform Future International Practice: Protocol for a Demographic Review of Referred Families and Key Lessons LearnedEvangeline A Huis In 't Veld, Anouk M Kruse, Emma J Verwaaijen, et al.
Breast Cancer Research and Treatment|October 25, 2006
Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imagingLeilani Morales, Steven Pans, Robert Paridaens, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 24, 2011
ESGO statement on the role of CA-125 measurement in follow-up of epithelial ovarian cancerAte G J van der Zee, Nicoletta Colombo, Gerald Gitsch, et al.
Gynecologic Oncology|June 23, 2019
PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumorsMonica Tang, Rachel L O'Connell, Frederic Amant, et al.
Carcinogenesis|December 15, 2010
Progesterone receptor gene variants and risk of endometrial cancerTracy A O'Mara, Paul Fahey, Kaltin Ferguson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2010
Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosisVanya Van Belle, Ben Van Calster, Olivier Brouckaert, et al.
Breast (Edinburgh, Scotland)|April 29, 2014
Prediction of non-sentinel lymph node involvement in breast cancer patients with a positive sentinel lymph nodeAnneleen Reynders, Olivier Brouckaert, Ann Smeets, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|June 26, 2024
Maternal death by cancer in pregnancy: A descriptive study of the International Network on Cancer, Infertility and PregnancyJoosje H Heimovaara, Evangeline A Huis In 't Veld, Christianne A R Lok, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 2, 2015
Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesionsSabrina Croce, Agnes Ribeiro, Celine Brulard, et al.
Bioinformatics (Oxford, England)|August 23, 2024
MetDecode: methylation-based deconvolution of cell-free DNA for noninvasive multi-cancer typingAntoine Passemiers, Stefania Tuveri, Dhanya Sudhakaran, et al.
Pageof 18